Cargando…

Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis

OBJECTIVE: To examine whether obesity/overweight is a risk predictor for breast cancer recurrence and death by menopausal status in a retrospective study. METHODS: We performed a retrospective analysis of 1017 breast cancer patients treated in our hospital from January 2004 to December 2012. Three g...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li, Zhu, Yulan, Qian, Qi, Tang, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039647/
https://www.ncbi.nlm.nih.gov/pubmed/29952978
http://dx.doi.org/10.1097/MD.0000000000011220
_version_ 1783338718780719104
author Sun, Li
Zhu, Yulan
Qian, Qi
Tang, Liming
author_facet Sun, Li
Zhu, Yulan
Qian, Qi
Tang, Liming
author_sort Sun, Li
collection PubMed
description OBJECTIVE: To examine whether obesity/overweight is a risk predictor for breast cancer recurrence and death by menopausal status in a retrospective study. METHODS: We performed a retrospective analysis of 1017 breast cancer patients treated in our hospital from January 2004 to December 2012. Three groups were divided according to body mass index (BMI) when breast cancer diagnosis: normal weight, BMI < 25.0 kg/m(2); overweight, 25.0≤BMI < 30.0 kg/m(2); and obesity, BMI≥30.0 kg/m(2). The clinicopathological characteristics and clinical outcomes of patients within 5 years following breast cancer diagnosed were analyzed. Subgroup analyses of BMI on breast cancer prognosis were analyzed according to the menopausal status when breast cancer diagnosis. The Cox proportional hazards model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: Overweight and obesity groups were associated with larger size tumors, older age, increased proportion of postmenopausal patients and less patients choosing anthracycline and/or taxane regimen. The 5-year disease-free survival (DFS) and overall survival (OS) decreased in overweight and obese patients (P < .001), and both overweight and obesity were independent predictors for increased risks of breast cancer relapse and death (P < .001). When stratified by menopausal status, both overweight and obesity were associated with reduced 5-year DFS and OS in postmenopausal patients (P < .050), and multivariate analysis showed that the risk of relapse and breast cancer mortality in these 2 groups also increased (P < .050). Among premenopausal patients, the risks of relapse and death were significantly increased in obesity group rather than overweight group by multivariate analysis. CONCLUSION: Overweight and obesity might be independently associated with poorer prognosis for breast cancer patients, and the effects of overweight on the breast cancer prognosis seem to be related to menopausal status.
format Online
Article
Text
id pubmed-6039647
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-60396472018-07-16 Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis Sun, Li Zhu, Yulan Qian, Qi Tang, Liming Medicine (Baltimore) Research Article OBJECTIVE: To examine whether obesity/overweight is a risk predictor for breast cancer recurrence and death by menopausal status in a retrospective study. METHODS: We performed a retrospective analysis of 1017 breast cancer patients treated in our hospital from January 2004 to December 2012. Three groups were divided according to body mass index (BMI) when breast cancer diagnosis: normal weight, BMI < 25.0 kg/m(2); overweight, 25.0≤BMI < 30.0 kg/m(2); and obesity, BMI≥30.0 kg/m(2). The clinicopathological characteristics and clinical outcomes of patients within 5 years following breast cancer diagnosed were analyzed. Subgroup analyses of BMI on breast cancer prognosis were analyzed according to the menopausal status when breast cancer diagnosis. The Cox proportional hazards model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: Overweight and obesity groups were associated with larger size tumors, older age, increased proportion of postmenopausal patients and less patients choosing anthracycline and/or taxane regimen. The 5-year disease-free survival (DFS) and overall survival (OS) decreased in overweight and obese patients (P < .001), and both overweight and obesity were independent predictors for increased risks of breast cancer relapse and death (P < .001). When stratified by menopausal status, both overweight and obesity were associated with reduced 5-year DFS and OS in postmenopausal patients (P < .050), and multivariate analysis showed that the risk of relapse and breast cancer mortality in these 2 groups also increased (P < .050). Among premenopausal patients, the risks of relapse and death were significantly increased in obesity group rather than overweight group by multivariate analysis. CONCLUSION: Overweight and obesity might be independently associated with poorer prognosis for breast cancer patients, and the effects of overweight on the breast cancer prognosis seem to be related to menopausal status. Wolters Kluwer Health 2018-06-29 /pmc/articles/PMC6039647/ /pubmed/29952978 http://dx.doi.org/10.1097/MD.0000000000011220 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle Research Article
Sun, Li
Zhu, Yulan
Qian, Qi
Tang, Liming
Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis
title Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis
title_full Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis
title_fullStr Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis
title_full_unstemmed Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis
title_short Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis
title_sort body mass index and prognosis of breast cancer: an analysis by menstruation status when breast cancer diagnosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039647/
https://www.ncbi.nlm.nih.gov/pubmed/29952978
http://dx.doi.org/10.1097/MD.0000000000011220
work_keys_str_mv AT sunli bodymassindexandprognosisofbreastcancerananalysisbymenstruationstatuswhenbreastcancerdiagnosis
AT zhuyulan bodymassindexandprognosisofbreastcancerananalysisbymenstruationstatuswhenbreastcancerdiagnosis
AT qianqi bodymassindexandprognosisofbreastcancerananalysisbymenstruationstatuswhenbreastcancerdiagnosis
AT tangliming bodymassindexandprognosisofbreastcancerananalysisbymenstruationstatuswhenbreastcancerdiagnosis